A crystalline alkaloid obtained from morphia. It is a powerful emetic.
A drug being studied in the lab to treat severe Parkinson's. It is a form of morphine that can increase the amount of dopamine available in the brain, thereby decreasing symptoms of Parkinson's.
A derivative of morphine and a dopamine agonist. Currently experimentally used as injectable treatment for severe Parkinson's.
a morphine derivative that is not as strong as morphine; used as an emetic and in small doses as a sedative
A dopamine agonist drug, used to treat Parkinson's, which is administered by subcutaneous (under the skin) injection or infusion pump. Other administration methods such as nasal (via the nose), sublingual (under the tongue).
A derivative of morphine and a dopamine agonist. Experimentally used now as injectable treatment for severe PD.
dopamine agonist given as a continuous subcutaneous infusion or as a subcutaneous injection. Apomorphine is used to alleviate the symptoms of severe PD that is responding poorly to levodopa. It is of particular benefit in patients with PD that experience ‘off’-times that last more than 30 minutes as it reverses symptoms within 10-15 minutes
Apomorphine is a type of dopaminergic agonist, a morphine derivative. Apomorphine is a relatively non-selective dopamine receptor agonist, having possible slightly higher affinity for D2-like dopamine receptors.